Search clinical trials for: Elisio-210H

Total 389 results

Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

Hypertension

Korea, Republic of
Nipro Europe N.V.

Completed

In Vivo Evaluation of the Nipro Elisio™ Dialyzer

Chronic Kidney Disease

France
Poitiers University Hospital
Baxter Healthcare Corporation

Completed

Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (THERANOVA)

End Stage Renal Disease | Dialysis Related Complication | Dialysis Amyloidosis

France
Changi General Hospital
National Taiwan University Hospital; Asan Medical Center

Completed

RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

Pancreatic Diseases | Pancreatic Neoplasm

Singapore
Royal Free Hampstead NHS Trust

Completed

Study to Assess Clearances and Bio-compatibility of ELISIO Dialyzer

Chronic Kidney Disease

United Kingdom
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Chronic Kidney Disease

United States
Stanford University

Completed

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

Pancreatic Adenocarcinoma

United States
Selayang Hospital

Completed

A Randomised, Open-Label, Cross Over Group, Single-Centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-Off Membrane Dialyser Compared With High Flux Dialyser Among Patients With Chronic Haemodialysis (HD-1)

Quality of Life | Dialysis Amyloidosis | Hemodialysis-Associated Amyloidosis

Malaysia
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
Response Pharmaceuticals

Completed

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

Hypertension

Germany
Response Pharmaceuticals

Completed

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

Hypertension

United Kingdom
Zai Lab Pty. Ltd.

Unknown

Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis

Australia
UConn Health
Dialysis Clinic, Inc.; Nipro Medical Corporation

Completed

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H (bisphenol-A)

End Stage Renal Disease
Johnson & Johnson Surgical Vision, Inc.

Completed

Evaluation of the LipiFlow System With a New Activator

Meibomian Gland Dysfunction

United States
Population Health Research Institute
Canadian Institutes of Health Research (CIHR); Abbott Medical Devices

Completed

Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor (ASSERT-II)

Atrial Fibrillation

Canada, Netherlands
Washington University School of Medicine
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Collaborative Tinnitus Research at Washington University (CTRWU)

Subjective Tinnitus

United States
MBX Biosciences

Completed

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects

Healthy

United States
Vanderbilt-Ingram Cancer Center
Astex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.

Withdrawn

ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
InSightec

Completed

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

Pain | Bleeding | Uterine Fibroids

United Kingdom, Israel, France, Russian Federation
Stanford University

Withdrawn

MR Guided High Intensity Focused Ultrasound for Lumbar Back Pain

Lumbar Facet Joint Pain

United States
Baxter Healthcare Corporation
Gambro Dialysatoren GmbH

Completed

Permeability Enhancement to Reduce Chronic Inflammation (PERCI)

Inflammation | End Stage Renal Disease

Germany
InSightec

Completed

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Pain | Bone Cancer | Bone Metastases

Israel
Emine Yıldırım

Not yet recruiting

The Effect of the Modified Simulation Model on Self-Efficacy, Anxiety, and Academic Motivation in Episiotomy Training (Episiotomy)

Anxiety | Simulation | Episiotomy
Hong Kong Baptist University

Not yet recruiting

A Chinese Herbal Medicine for IBS-C (CDD2105RCT1)

Constipation-predominant Irritable Bowel Syndrome
Innolake Biopharm

Recruiting

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Melanoma | Soft Tissue Sarcoma | Cervical Cancer | Head and Neck Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Classic Hodgkin Lymphoma

China
InSightec

Withdrawn

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

Bleeding | Pelvic Pain | Uterine Fibroids

United Kingdom
Response Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Raynaud's Disease

Germany
Kissei Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Uterine Fibroids (MeSH Heading: Leiomyoma)

Japan
Xoc Pharmaceuticals
Celerion

Active, not recruiting

Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects

Parkinson's Disease

United States
Matthew Bucknor
Focused Ultrasound Foundation; InSightec-TxSonics

Recruiting

Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma (HIFU-UPS)

Undifferentiated Pleomorphic Sarcoma

United States
University Children's Hospital, Zurich

Completed

Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP) (myCAP)

Diagnosis | Childhood Pneumonia | Mycoplasma Pneumonia | Antibody-secreting Cells | Enzyme-linked Immunospot (ELISpot)
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

Endometriosis

Japan
CTI BioPharma

Completed

CT-2106 for the Second Line Treatment of Ovarian Cancer

Ovarian Cancer

France, United Kingdom, Italy
Praxisverbund Dialyse und Apherese

Completed

Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration

End Stage Kidney Disease

Germany
Guangdong Hengrui Pharmaceutical Co., Ltd

Enrolling by invitation

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

Kidney Transplantation

China
University of Washington
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

Depression | Chronic Pain | Fibromyalgia

United States
Duke University

Not yet recruiting

Electrical Impedence Tomography With ENLIGHT2100

Extubation

United States
InSightec

Completed

Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study

Localized Low-Intermediate Risk Prostate Cancer

United Kingdom, Israel, Canada, Italy, Singapore
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis

Endometriosis

Japan
InSightec

Terminated

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Bone Metastases

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Endometriosis

Japan
EXcorLab GmbH
Nipro Europe N.V.

Completed

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Chronic Kidney Disease

Belgium
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Precancerous Condition | Anal Cancer

United States
Mayo Clinic
Eli Lilly and Company

Completed

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

Depression

United States
Armgo Pharma, Inc.
National Institute of Nursing Research (NINR); National Institute of Neurological... and other collaborators

Completed

S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)

RYR-1 Myopathy

United States
Vertex Pharmaceuticals Incorporated

Terminated

Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Cervical Spinal Cord Injury

United States, Canada
H. Lee Moffitt Cancer Center and Research Institute
Elucent Medical

Completed

Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses

Breast Cancer

United States
Lumenis Be Ltd.

Unknown

Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

Stone Clearance

United States
University of Missouri-Columbia
Dialysis Clinic, Inc.; Nipro Medical Corporation

Completed

A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients

End Stage Renal Disease (ESRD)

United States
TCI Co., Ltd.

Recruiting

The Effect of Adaptogen Elixir on Sleep Improvement

Sleep Disorder | Anxiety Disorders

Taiwan

Search clinical trials for: Elisio-210H

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations